Cotton Futures Decline as Memorial Day Weekend Approaches Palantir Technologies Stock Declines 34 from Recent Highs Market Analysis Indian Government to Divest 2 Stake in Coal India via Offer for Sale at Rs 412 Floor Price Bear Call Spread Opportunities Highlighted for May 26 Expiration Dropboxs Fully Remote Model Strengthens Recruitment and Retention as Office Return Trends Continue Shyam Srinivasan Blends Banking and Cricket Wisdom in New Book Better Never Stops HCKT Q1 2026 Earnings EPS Misses Estimates Despite Stock Rally PFSI Q1 2026 Earnings EPS Misses Estimates Amid Challenging Environment TRMB Q1 2026 Earnings EPS Beats Estimates by 794 as Stock Edges Higher FRME Q1 2026 Earnings EPS Beats Estimates by Nearly 9 as Stock Edges Lower LLYVK Q4 2025 Earnings EPS Nearly Matches Estimates but Surprise Miss and Flat Revenue Weigh on Sentiment WFG Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Surprise Oxford Lane Capital Corp 7125 Series 2029 Preferred Stock OXLCN Edges Higher Amid Steady Demand Under Armour UAA Rallies 29 as Shares Test Key Resistance Near 600 Dragonfly Energy Holdings Warrant DFLIW Holds at 005 Amid Tight Consolidation Axe Compute Inc AGPU Sinks 6 as Selling Pressure Intensifies Testing Key Support Near 507 Cal Redwood Acquisition Corp Units CRAQU Holds Steady at 1018 Little Movement Steady Support Intuit Earnings Results Challenge Morgan Stanleys Stock Forecast as Market Awaits Implications BeyondSpring Q1 2026 Earnings Narrowed Loss Per Share and Positive Stock Movement BGM Group Ltd BGM Shows Modest Uptick as Stock Tests Key Resistance Level Planet Fitness PLNT Holds Steady Near Support as Price Action Remains RangeBound Hudson Technologies HDSN Slides 21 as Key Support Level Approaches Chegg Inc CHGG Surges 84 as Stock Bounces From Key Support Zone Preferred Bank PFBC Holds Steady Near 95 as Support and Resistance Levels Come into Focus Miluna Acquisition Corp Warrant MMTXW Holds Steady Near Support After Flat Session BioVie Inc BIVI Declines 526 Testing Critical Support Near 137 Monopar Therapeutics MNPR Surges 3 as Biotech Momentum Builds Tests Key Resistance